These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

And I was getting excited." Novo Nordisk spent the next 20 years working on that GLP-1 molecule before Ozempic finally made it to market as a Type 2 diabetes drug in 2017. It took another four ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and Wegovy, have led to at least 100 hospitalizations and 10 deaths.